Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Fallopian Tube Neoplasms × Trastuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 208 Stomach Neoplasms 17 Neoplasm Metastasis 13 Breast Neoplasms, Male 13 Neoplasms 8 Esophageal Neoplasms 8 Brain Neoplasms 7 Inflammatory Breast Neoplasms 6 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Triple Negative Breast Neoplasms 3 Urologic Neoplasms 2 HER2-positive Breast Cancer 2 Gallbladder Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Rectal Neoplasms 1 Patient Preference 1 Patient Compliance 1 Osteitis Deformans 1 Neoplasm, Residual 1 Meningeal Neoplasms 1 Malignant Solid Neoplasm 1 Locally Advanced Breast Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Hormone Receptor Positive Breast Cancer 1

Interventions

Paclitaxel 49 Carboplatin 47 Bevacizumab 35 Taxes 22 liposomal doxorubicin 18 Gemcitabine 16 pembrolizumab 14 Immunoglobulin G 14 Disulfides 14 Topotecan 10 Cisplatin 9 rucaparib 8 olaparib 7 Docetaxel 7 Cyclophosphamide 7 mirvetuximab soravtansine 6 cediranib 6 Magnetic Resonance Spectroscopy 6 Doxorubicin 6 pazopanib 5 Specimen Handling 5 Nivolumab 5 sargramostim 4 niraparib 4 Surgical Procedures, Operative 4 Cytoreduction Surgical Procedures 4 Albumin-Bound Paclitaxel 4 fludarabine phosphate 3 belinostat 3 avelumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡